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Background-—Experimental studies demonstrate that high aortic pressure in late systole relative to early systole causes greater
myocardial remodeling and dysfunction, for any given absolute peak systolic pressure.
Methods and Results-—We tested the hypothesis that late systolic hypertension, deﬁned as the ratio of late (last one third of
systole) to early (ﬁrst two thirds of systole) pressure–time integrals (PTI) of the aortic pressure waveform, independently predicts
incident heart failure (HF) in the general population. Aortic pressure waveforms were derived from a generalized transfer function
applied to the radial pressure waveform recorded noninvasively from 6124 adults. The late/early systolic PTI ratio (L/ESPTI) was
assessed as a predictor of incident HF during median 8.5 years of follow-up. The L/ESPTI was predictive of incident HF (hazard ratio
per 1% increase=1.22; 95% CI=1.15 to 1.29; P<0.0001) even after adjustment for established risk factors for HF (HR=1.23; 95%
CI=1.14 to 1.32: P<0.0001). In a multivariate model that included brachial systolic and diastolic blood pressure and other standard
risk factors of HF, L/ESPTI was the modiﬁable factor associated with the greatest improvements in model performance. A high
L/ESPTI (>58.38%) was more predictive of HF than the presence of hypertension. After adjustment for each other and various
predictors of HF, the HR associated with hypertension was 1.39 (95% CI=0.86 to 2.23; P=0.18), whereas the HR associated with a
high L/E was 2.31 (95% CI=1.52 to 3.49; P<0.0001).
Conclusions-—Independently of the absolute level of peak pressure, late systolic hypertension is strongly associated with incident
HF in the general population. ( J Am Heart Assoc. 2015;4:e001335 doi: 10.1161/JAHA.114.001335)
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H eart failure (HF) affects 2.4% of the US population and10% of individuals aged >75 years. The burden of HF
has increased markedly over the last few years. Data from the
American Heart Association1,2 indicated that the number of
new HF cases in the United States increased from 348 000 in
2000 to 670 000 in 2007, representing a 93% increase over
this time period. A recent American Heart Association policy
statement estimated that the number of people with HF in the
United States may increase from 5 million in 2012 to >8
million in 2030.3 Once HF ensues, mortality is high, with 50%
of Medicare beneﬁciaries not surviving 3 years after an HF
hospitalization.4 Similarly, HF is associated with a markedly
impaired quality of life5–8 and high societal costs.3 Therefore,
characterizing the risk factors for the development of new-
onset HF is an important goal, in order to design better
preventive strategies.
A series of animal and human studies have linked late
systolic load with myocardial remodeling and dysfunction.9–21
Experimental data in rat models demonstrate that, for any
given level of left ventricular (LV) peak systolic pressure, an
afterload pattern that results in predominantly late-systolic
hypertension, rather than early-systolic hypertension, causes
greater LV remodeling and ﬁbrosis.13 Studies in healthy
instrumented dogs have shown that balloon inﬂations in the
ascending aorta during late systole impair diastolic relaxation
more than early systolic inﬂation, for any given increase in
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peak systolic LV pressure.9,19–21 More recently, it has been
shown that late systolic hypertension assessed from a carotid
pressure waveform16 or an invasively measured aortic
pressure waveform18 is associated with impaired early
diastolic relaxation in humans. This implicates the loading
sequence (early versus late systolic) as a potential mecha-
nistic determinant of myocardial dysfunction in humans,
independent of the absolute systolic blood pressure level.
However, whether late systolic hypertension predicts the risk
of incident HF in the general population is unknown. In this
study, we tested the hypothesis that a simple surrogate of the
loading sequence, deﬁned as the ratio of late systolic (last one
third of systole) to early systolic (ﬁrst two thirds of systole)
pressure-time integrals (PTI) of the central pressure wave-
form, is independently associated with an increased risk of
incident HF in a multiethnic sample from general population
free of clinically manifest cardiovascular disease at baseline.
Methods
Study Population
The Multiethnic Study of Atherosclerosis enrolled 6814 men
and women aged 45 to 84 years who identiﬁed themselves as
white, African American, Hispanic, or Chinese and were free of
clinically apparent cardiovascular disease, from 6 US com-
munities between 2000 and 2002.22 The study was approved
by the institutional review boards of participating centers, and
participants gave informed consent.
Data Collection
Standardized questionnaires were used to obtain information
about cardiovascular risk factors and medication use. Resting
blood pressure was measured 3 times with subjects in the
seated position with a Dinamap-Pro100 oscillometric sphyg-
momanometer (GE Medical Systems, Waukesha, WI). The
average of the last 2 measurements was used. Hypertension
was deﬁned as systolic blood pressure ≥140 mm Hg,
diastolic blood pressure ≥90 mm Hg, or antihypertensive
medication use.23 Serum total cholesterol, high-density-lipo-
protein (HDL) cholesterol, and glucose were measured after a
12-hour fast. Diabetes mellitus was deﬁned as fasting glucose
≥126 mg/dL or hypoglycemic medication use.24
Hemodynamic Measurements
Radial arterial waveforms were recorded during 30 s at
baseline, using the HDI/PulseWave-CR2000 tonometry device
(Hypertension Diagnostics, Eagan, MN), digitized at 200 Hz
and exported for ofﬂine processing using custom-designed
software written in Matlab (The Mathworks, Natick, MA). All
pressure waveforms were visually inspected by an investiga-
tor (J.A.C.) for quality and physiologic consistency. We
excluded averaged waveforms that met any of the following
criteria: (1) A nonphysiologic appearance (usually from
bigeminy, trigeminy, or contamination of the signal average
by aberrantly recorded complexes); (2) Cardiac cycle duration
variation ≥10%; (3) Pulse height (beat-to-beat pulse pressure)
variation ≥20%; and (4) Less than 10 adequately recorded
cycles available for signal averaging.
A generalized transfer function25 was applied to the radial
pressure waveform to obtain a central pressure waveform, as
previously described.17 The aortic augmentation index was
computed as the second/ﬁrst systolic peak9100. Derived
aortic pressure tracings were also analyzed by measuring the
area under the central pressure curve (pressure–time integral)
during the ﬁrst (PTI1), second (PTI2) and last (PTI3) one third of
systole, as previously described.16 We computed a dimension-
less ratio of PTI3/(PTI1+PTI2) as a quantitative index of late
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Figure 1. Assessment of early vs late aortic systolic pressure. The tonometric radial pressure waveform
(left) is used to derive an aortic pressure waveform (right). The duration of the systolic portion of the aortic
pressure waveform was then split in 3 equal tertiles to compute the area under the curve (pressure–time
integral [PTI]) corresponding to each tertile (PTI1, PTI2, and PTI3). The late/early systolic PTI (L/ESPTI) was
then computed as PTI3/(PTI1+PTI2). AIx indicates augmentation index; P1, ﬁrst systolic peak; P2, second
systolic peak; 1, 2 and 3, 1st, 2nd and 3rd pressure-time integrals of systole, respectively.
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systolic hypertension (Figure 1). This ratio, which we call late/
early systolic pressure–time-integral (L/ESPTI) was multiplied by
100 and thus represents PTI3 expressed as a percentage of
PTI1+PTI2. Examples of central pressure waveforms demon-
strating high and low L/ESPTI are shown in Figure 2.
Event Adjudication
In addition to 4 on-site examinations, a telephone interviewer
contacted participants every 9 to 12 months to inquire about
incident cardiovascular events. Two physicians independently
reviewed copies of medical records and death certiﬁcates for
hospitalizations and outpatient cardiovascular diagnoses, for
blinded end-point classiﬁcation using prespeciﬁed criteria.26
The diagnosis of HF was established by “deﬁnite” criteria,
which required clinical symptoms (eg, dyspnea) or signs (eg,
edema), a physician HF diagnosis, and medical treatment for
HF in addition to (1) pulmonary edema/congestion by chest
radiograph and/or (2) dilated ventricle or poor LV function by
echocardiography or ventriculography, or evidence of LV
diastolic dysfunction.
Statistical Analysis
We examined the association between hemodynamic mea-
sures and time to HF using the Kaplan–Meier method and Cox
regression. Model goodness-of-ﬁt was assessed with the
Akaike’s information criterion (AIC) and Bayesian information
criterion.27,28 Model discrimination was assessed with the
Harrel’s c-index (which is analogous to the area under the
receiver-operator-characteristic curve).27,29 Improvements in
subject reclassiﬁcation by L/ESPTI were further assessed
using the category-free net reclassiﬁcation improve-
ment,27,29,30 which depends on the increased probability that
a new model will categorize case subjects as higher risk and
decreased probability that it will categorize control subjects
as lower risk, compared to a base model. We also computed
the integrated discrimination improvement, which expresses
the improvement in discrimination slopes (mean difference in
predicted probabilities between case and control participants)
between the base model and new model.27,29–31 Various
indices of model performance were used to (1) assess the
added predictive value of L/ESPTI, and (2) compare the
predictive value of L/ESPTI to that of well-established risk
factors.27
We also compared the risk associated with late systolic
hypertension (as deﬁned from the L/ESPTI) versus the risk
associated with hypertension, deﬁned by standard criteria
JNC-7 based on brachial systolic and diastolic blood
pressure.23 We therefore deﬁned a “high” L/ESPTI based on
a cut point chosen to match the prevalence of “high L/ESPTI”
to the prevalence of hypertension (deﬁned by standard
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Figure 2. Examples of central pressure waveforms demonstrating a high (top row) and low (bottom row) late/early systolic pressure–time
integral (L/ESPTI). AIx indicates Augmentation index.
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criteria) in the sample. Since the prevalence of hypertension
in the sample at baseline was 45%, a “high L/ESPTI” was
deﬁned as a value above the 55th percentile of L/ESPTI
(58.38%). Tests were 2-sided with a=0.05. Analyses were
performed using SPSS v17 (SPSS Inc, Chicago, IL). Net
reclassiﬁcation improvement and integrated discrimination
improvement were computed using the R package survI-
DINRI.32
Results
Of 6336 participants who underwent radial tonometry, 6152
(97.1%) had technically adequate data. Twenty-eight partici-
pants had no follow-up information, leaving 6124 participants
in the analysis. Table 1 shows baseline characteristics of
participants included in this study. The L/ESPTI ratio was
weakly correlated with systolic blood pressure (R2=0.116;
P<0.0001), heart rate (R2=0.11; P<0.0001), age (R=0.15;
P<0.0001), and was greater in women (59.9%; 95% CI=59.8 to
60) than men (58.3%; 95% CI=58.2 to 58.4; P<0.0001). A
signiﬁcant difference between men and women was present
after adjustment for race, diabetes, blood pressure, body
height and weight, smoking, glomerular ﬁltration rate, antihy-
pertensive medication use, total cholesterol and HDL choles-
terol (adjusted mean for women=59.4%; 95% CI=59.3 to 59.5;
adjusted mean for men=58.8; 95% CI=58.7 to 58.9;
P<0.0001).
During the course of follow-up (median: 8.47 years,
interquartile range: 7.74 to 8.64), 135 participants experi-
enced a ﬁrst episode of HF. Hazard ratios (HR) for incident HF
associated with a 1% increase in L/ESPTI in unadjusted
analysis and various adjusted models are shown in Table 2.
Standardized HR (ie, corresponding to 1 SD increase in L/E)
are also shown. In unadjusted analyses (Model 1), a greater
L/E ratio predicted a higher risk of incident HF (HR per 1%
increase=1.22; 95% CI=1.15 to 1.29; P<0.0001). The HR per
SD increase in the L/E ratio was 1.74 (95% CI=1.49 to 2.04;
P<0.0001). These estimates were robust to multivariable
adjustment for various confounders (Models 2 to 4, Table 2).
In a model that included age, ethnicity, gender, diabetes
mellitus, systolic and diastolic blood pressure, body mass
index, antihypertensive medication use, total cholesterol, HDL
cholesterol, current smoking, heart rate, estimated glomerular
ﬁltration rate, and traditional systolic indices derived from
pulse-wave analysis (aortic augmentation index and pulse
pressure ampliﬁcation; Model 4, Table 2), the adjusted HR per
1% increase in the L/ESPTI ratio was 1.24 (1.14 to 1.34:
Table 1. Baseline Characteristics of Study Participants
(n=6124)
Characteristic Median (IQR) or Count (%)
Number of HF events 135 (2.2)
Age, y 62 (53 to 70)
Sex
Male 2918 (47.6)
Female 3207 (52.4)
Ethnicity
White 2319 (37.9)
African American 1659 (27.1)
Chinese American 751 (12.23)
Hispanic American 1396 (22.8)
Body mass index, kg/m2 27.5 (24.5 to 31.2)
Total cholesterol, mg/dL 192 (171 to 215)
LDL cholesterol, mg/dL 116 (96 to 136)
HDL cholesterol, mg/dL 48 (40 to 59)
Triglycerides, mg/dL 111 (78 to 160)
Diabetes mellitus 776 (12.7)
Current smoking 2222 (36.3)
Hypertension 2729 (44.6)
Estimated glomerular filtration
rate, mLmin11.73 m2
79.7 (69.6 to 92)
Hypertension medication use 2269 (37.0)
Brachial SBP, mm Hg 123.5 (111 to 139.5)
Brachial DBP, mm Hg 72 (65 to 78.5)
L/ESPTI, % 59 (57.2 to 60.9)
Heart rate, bpm 63 (57 to 70)
DBP indicates diastolic blood pressure; HDL, high-density lipoprotein; HF, heart failure;
IQR, interquartile range; L/ESPTI, late/early systolic pressure–time integral; LDL, low-
density lipoprotein; SBP, systolic blood pressure.
Table 2. Results of Cox Proportional Hazards Models
Examining the Relationship Between the L/ESPTI at Baseline
and the Risk of Heart Failure During Follow-Up (Number of
Events=135)
Hazard Ratio Per 1%
Increase in L/ESPTI
(95% CI)
Standardized Hazard
Ratio (95% CI)* P Value
Model 1 1.22 (1.15 to 1.29) 1.74 (1.49 to 2.04) <0.0001
Model 2 1.27 (1.18 to 1.36) 1.95 (1.60 to 2.36) <0.0001
Model 3 1.22 (1.14 to 1.32) 1.76 (1.44 to 2.16) <0.0001
Model 4 1.24 (1.14 to 1.34) 1.82 (1.45 to 2.28) <0.0001
Model 1 is unadjusted (n=6124). Model 2 (n=6124) is adjusted for age, ethnicity, gender,
and heart rate. Model 3 (n=6107) is additionally adjusted for diabetes mellitus, systolic
and diastolic blood pressure, and body mass index. Model 4 (n=6098) is additionally
adjusted for antihypertensive medication use, total cholesterol, HDL cholesterol, current
smoking, estimated glomerular ﬁltration rate, aortic augmentation index, and aortic-to-
radial pulse pressure ampliﬁcation. HDL indicates high-density lipoprotein; L/ESPTI, late/
early systolic pressure–time integral.
*The standardized hazard ratio (HR) is the HR per 1-SD increase in L/ESPTI. The SD for
L/ESPTI is 2.8%.
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P<0.0001) and the standardized HR was 1.82 (95% CI=1.45
to 2.28). In this model, neither aortic augmentation index
(standardized HR=0.94; 95% CI=0.76 to 1.15; P=0.53) nor
pulse pressure ampliﬁcation (standardized HR=0.94; 95%
CI=0.73 to 1.33; P=0.94) were predictive of incident HF.
Table 3 shows the signiﬁcant predictors of HF in model 4,
along with standardized HR, Wald statistics, and other
measures of improvements in model performance (Bayesian
information criterion, Akaike’s information criterion, and
c-index) by each signiﬁcant independent predictor of HF in
this model. Of all the variables in this model, L/ESPTI was the
modiﬁable factor associated with the highest standardized
HR, Wald statistic, the greatest reduction in Akaike’s
information criterion and Bayesian information criterion, and
the greatest improvements in c-statistics. These improve-
ments in model performance were also greater than those
provided by both systolic and diastolic blood pressure
together (bottom of Table 3). The addition of L/ESPTI to a
model containing all other variables shown in Table 3 resulted
in a category-free net reclassiﬁcation improvement of 0.24
(95% CI=0.05 to 0.45; P=0.027) and an integrated discrim-
ination improvement of 0.015 (95% CI=0.003 to 0.04;
P<0.0001).
Figure 3 shows the HR associated with hypertension
(prevalence=45%) or a high L/ESPTI (ie, >0.594 or 59.4%;
prevalence=45%) in various Cox models. All models include
the presence of hypertension and a high L/ESPTI as predictors
of HF. In unadjusted analyses, both hypertension (HR=2.61;
95% CI=1.79 to 3.81; P<0.0001) and a high L/ESPTI (HR=2.08;
95% CI=1.44 to 3.01; P<0.0001) were signiﬁcant independent
predictors of HF. A high L/ESPTI was a robust independent
predictor of HF with increasing adjustment for confounders.
In contrast, hypertension did not signiﬁcantly predict HF in a
model that adjusted for a high L/E and various confounders
(age, ethnicity, gender, heart rate, diabetes mellitus, body
mass index, antihypertensive medication use, total choles-
terol, HDL cholesterol, current smoking, and estimated
glomerular ﬁltration rate; Model 4 in Figure 3). In this model,
the HR associated with hypertension was 1.39 (95% CI=0.86
to 2.23; P=0.18), whereas the HR associated with a high L/E
was 2.31 (95% CI=1.52 to 3.49; P<0.0001). The cumulative
hazard for HF among participants stratiﬁed according to the
presence or absence of hypertension or a high L/ESPTI,
adjusted for age, ethnicity, gender, heart rate, diabetes
mellitus, body mass index, antihypertensive medication use,
total cholesterol, HDL cholesterol, current smoking, and
estimated glomerular ﬁltration rate is shown in Figure 4. It
can be seen that participants with a high L/E demonstrated
the highest hazard for HF, even in the absence of hyperten-
sion, whereas participants with a low L/E (both normotensive
and hypertensive) comprised the strata with the lowest hazard
for HF.
There was no evidence of effect modiﬁcation by gender (P
for interaction=0.26) or age (P for interaction=0.96) regarding
the association between L/ESPTI and incident HF.
Discussion
Our study demonstrates that late systolic central hyperten-
sion, assessed noninvasively via analysis of a central pressure
waveform derived from radial tonometry, is an important
independent risk factor for new-onset HF among adults in the
Table 3. Predictors of Incident Heart Failure in Multivariable Analysis (n=6098)
Full Model With Adjusted HR (c-Index=0.81)
Standardized HR* Wald Statistic P Value Change in BIC† Change in AIC† Change in c-Index‡
Age 1.54 (1.22 to 1.95) 12.968 <0.0001 8.4 11.30 0.015
Male gender 2.05 (1.63 to 2.58) 37.234 <0.0001 33.5 36.40 0.031
Body mass index 1.29 (1.06 to 1.56) 6.618 0.01 1.4 4.30 0.01
Diabetes mellitus 1.20 (1.04 to 1.37) 6.442 0.011 1.2 4.10 0.01
Systolic blood pressure 1.28 (1.00 to 1.62) 3.961 0.047 1.0 1.90 0.005
Diastolic blood pressure 0.77 (0.60 to 0.99) 4.264 0.039 0.6 2.30 0.005
Heart rate 1.45 (1.20 to 1.75) 15.261 <0.0001 9.7 12.60 0.011
L/ESPTI 1.78 (1.45 to 2.17) 30.948 <0.0001 23.8 26.70 0.016
Systolic and diastolic blood
pressure added together§
— — — 0.10 2.80 0.005
All models are adjusted for ethnicity, antihypertensive medication use, total cholesterol, high-density lipoprotein cholesterol, current smoking, and estimated glomerular ﬁltration rate. Only
signiﬁcant predictors of heart failure are shown. HR indicates hazard ratio; L/ESPTI, late/early systolic pressure–time integral.
*SDs are as follows: age, 10.2 years; body mass index, 5.5 kg/m2; systolic blood pressure, 21.4 mm Hg; diastolic blood pressure, 10.3 mm Hg; heart rate, 10 bpm; L/ESPTI, 2.8%.
†AIC, Akaike’s information criterion; BIC, Bayesian information criterion. For both, larger decreases (changes with negative sign) indicate a larger improvement in model ﬁt.
‡Larger increases indicate a larger improvement in model performance.
§This row presents improvements in model performance when both systolic and diastolic blood pressure are added to a model containing all other variables contained in the full model.
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general population. In our large multiethnic sample of adults
free of clinically apparent cardiovascular disease at baseline, a
simple ratio of late versus early central pressure in systole (L/
ESPTI) was a strong predictor of incident HF independent of
brachial systolic and diastolic blood pressure levels and other
established predictors of HF, and was associated with
important improvements in model performance and a signif-
icant population-attributable risk of HF.
For any given level of systolic blood pressure, a pattern
characterized by prominent late-systolic load has been
unequivocally demonstrated to exert deleterious effects on
LV structure and function in animal models,9,13,33 observa-
tions that have been supported by human studies.15,16
Consistent with these mechanistic data, our study indicates
that late systolic hypertension is an independent predictor of
HF risk.
The aortic pressure proﬁle is determined by the interac-
tions between the left ventricle and the load imposed by the
arterial tree.33 The hemodynamic determinants of late systolic
versus early systolic hypertension are different. Early systolic
pressure is a function of the pulsatile increase in pressure as
a result of the interaction between the LV and the proximal
aortic characteristic impedance, whereas late systolic pres-
sure is more dependent on the total compliance of the arterial
tree and wave reﬂections.14 Wave reﬂections arise at multiple
sites of impedance mismatch along the arterial tree (such as
points of branching or change in wall diameter or material
properties)33,34 and merge into a net reﬂected wave, which
increases late systolic pressure and reduces late systolic ﬂow
in the aorta. These arterial phenomena in turn relate
differentially to the LV wall stress at different time points
during ejection.35 During early ejection, active development of
ﬁber cross-bridges occurs in the electrically activated myo-
cardium and peak myocardial wall stress occurs,36 at a time
when systolic pressure coexists with quasidiastolic geometry.
Myocardial ﬁber shortening and ejection of blood determine a
progressive change in LV geometry, which causes a drop in
myocardial stress during mid-to-late systole. This phenome-
non, which appears to be favorable for the myocardium to
reduce the late systolic load imposed by wave reﬂections, is,
however, of variable magnitude and may be insufﬁcient and/
or compromised in the setting of low or low-normal LV
ejection fraction or in the presence of pronounced late
systolic arterial load.35–38 Indeed, an elevation of late systolic
Model 2
Model 3
Model 4
Model 1
Model 2
Model 3
Model 4
Model 1
L/ESPTI
SBP
1 2 3 40.50.33
Hazard Ratio
Figure 3. Hazard ratio associated with hypertension or a high
L/ESPTI in various Cox models. All models include the presence of
hypertension and a high L/ESPTI as predictors of HF. Model 1
(n=6124) includes no additional covariables. Model 2 (n=6124) is
adjusted for age, ethnicity, gender, and heart rate. Model 3
(n=6107) is additionally adjusted for diabetes mellitus and body
mass index. Model 4 (n=6098) is additionally adjusted for
antihypertensive medication use, total cholesterol, HDL choles-
terol, current smoking, estimated glomerular ﬁltration rate, aortic
augmentation index, and aortic-to-radial pulse pressure ampliﬁ-
cation. HDL indicates high-density lipoprotein; HF, heart failure;
L/ESPTI, late/early systolic pressure–time integral; SBP, systolic
blood pressure.
No  HTN   
Low  L/ESPTI
HTN   
Low  L/ESPTI
No HTN   
High L/ESPTI
HTN   
High L/ESPTI
Figure 4. Cumulative hazard curves for HF among participants
stratiﬁed according to the presence or absence of hypertension
(prevalence=45%) or a high L/ESPTI (set empirically to an identical
prevalence of 45% based on E/LSPTI). Curves are adjusted for age,
ethnicity, gender, heart rate, diabetes mellitus, body mass index,
antihypertensive medication use, total cholesterol, HDL choles-
terol, current smoking, and estimated glomerular ﬁltration rate.
The numbers of participants in each stratum are as follows: No
HTN/Low L/ESPTI=2214; HTN/Low L/ESPTI=1155; No HTN/High
L/ESPTI=1182; HTN/High L/ESPTI=1574. HDL indicates high-
density lipoprotein; HF, heart failure; L/ESPTI, late/early systolic
pressure time integral; HTN, hypertension; CHF, congestive heart
failure.
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LV wall stress relative to early wall stress has been shown to
be independently associated with diastolic dysfunction in
middle-aged adults.39
We have previously shown than reﬂection magnitude
estimated with a physiologic ﬂow approach independently
predicts the risk of incident HF in this cohort.17 Such an
approach is based on the relatively low variability of the ﬂow
waveform between individuals. It represents an approxima-
tion, which depends on the assumption of a physiologic ﬂow
waveform (rather than relying on measured ﬂow). Further-
more, it does not directly assess the timing of arterial
pressure during systole. In contrast, the approach under-
taken in the current study does not require the use of any
assumptions about ﬂow waveform morphology and provides
a direct quantiﬁcation of early versus late systolic central
hypertension. Furthermore, in contrast to augmentation
index, this index does not rely heavily on the high-frequency
components of the pulse wave contour, which tend to be
more susceptible to noise and which relate less consistently
between the radial and aortic locations.
Our study should be interpreted in the context of its
strengths and limitations. To our knowledge, this is the ﬁrst
study to demonstrate an association between late systolic
central hypertension and incident HF. Other strengths of our
investigation include the multiethnic community-based sam-
ple, standardized assessments, and careful event adjudica-
tion using deﬁnitive criteria for HF. However, it is important
to acknowledge several limitations. Our observational study
cannot prove a causal link between late systolic hyperten-
sion and HF, although our observational data should be
interpreted in the context of previous experimental studies,
which demonstrate a cause–effect relationship between late
systolic load and myocardial remodeling and dysfunction.9–
11,13,18–21 We did not measure aortic pressure directly, but
rather derived it from a generalized transfer function,
designed to reproduce the features of the central pressure
waveform. This approach has limitations, because it
assumes a ﬁxed relationship between the harmonic com-
ponents of pressure between the aorta and the radial
artery. However, this relationship is actually variable,
particularly for the higher harmonics of pressure. Since
participants had no known cardiovascular disease at
baseline, this cohort represents a particularly healthy
sample of the population at large which is, however, ideal
for examining early vascular changes predisposing to new-
onset HF. Finally, our study did not assess how the L/ESPTI
relates to incident HF with preserved ejection fraction
versus HF with reduced ejection fraction. This should be the
focus of future research.
In summary, in an ethnically diverse population free of
cardiovascular disease at baseline, late systolic hypertension
was independently associated with incident HF. The systolic
LV loading sequence may represent an important novel risk
factor for HF and a potential therapeutic target for primary HF
prevention.
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